ID: ALA3410743

Max Phase: Preclinical

Molecular Formula: C18H18O7

Molecular Weight: 346.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(C(=O)COC(=O)c2cc(OC)ccc2O)c(OC)c1

Standard InChI:  InChI=1S/C18H18O7/c1-22-11-5-7-15(19)14(8-11)18(21)25-10-16(20)13-6-4-12(23-2)9-17(13)24-3/h4-9,19H,10H2,1-3H3

Standard InChI Key:  YQCZSNWKMXTVPF-UHFFFAOYSA-N

Associated Targets(Human)

Krueppel-like factor 10 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 346.34Molecular Weight (Monoisotopic): 346.1053AlogP: 2.46#Rotatable Bonds: 7
Polar Surface Area: 91.29Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.13CX Basic pKa: CX LogP: 3.08CX LogD: 3.08
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.61Np Likeness Score: -0.29

References

1. Khedkar SA, Sun X, Rigby AC, Feinberg MW..  (2015)  Discovery of small molecule inhibitors to Krüppel-like factor 10 (KLF10): implications for modulation of T regulatory cell differentiation.,  58  (3): [PMID:25581017] [10.1021/jm5018187]
2.  (2017)  Use of small molecule inhibitors to klf10 for modulation of t regulatory cells and cancer immunotherapy,